Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Finckh

Showing results (51-60 of 225) with videos related to

Pageof 23
Sort By:
Arthritis and Rheumatism|February 1, 2007
Methotrexate as an alternative therapy for chronic calcium pyrophosphate deposition disease: an exploratory analysisAmélie Chollet-Janin, Axel Finckh, Jean Dudler, et al.
Joint Bone Spine|July 10, 2013
Primary prevention of rheumatoid arthritis: a qualitative study in a high-risk populationFiona Novotny, Sylvie Haeny, Patricia Hudelson, et al.
Obesity (Silver Spring, Md.)|February 7, 2009
BMI and severity of clinical and radiographic signs of hip osteoarthritisAnne Lübbeke, Sylvain Duc, Guido Garavaglia, et al.
Annals of the Rheumatic Diseases|February 2, 2012
Differential drug retention between anti-TNF agents and alternative biological agents after inadequate response to an anti-TNF agent in rheumatoid arthritis patientsSophie Martin Du Pan, Almut Scherer, Cem Gabay, et al.
Frontiers in Medicine|July 24, 2023
Brief report: can COVID-19 infection trigger rheumatoid arthritis-associated autoimmunity in individuals at risk for the disease? A nested cohort studyCeline Lamacchia, Benoit Gilbert, Olivia Studer, et al.
The Journal of Infectious Diseases|August 4, 2023
Susceptibility to COVID-19 and Immunologic Response to Vaccination in Patients With Immune-Mediated Inflammatory DiseasesAxel Finckh, Adrian Ciurea, Catherine E Raptis, et al.
BMJ Open|February 8, 2024
Comparative effectiveness of biologics in patients with rheumatoid arthritis stratified by body mass index: a cohort study in a Swiss registryEnriqueta Vallejo-Yagüe, Theresa Burkard, Axel Finckh, et al.
Annals of the Rheumatic Diseases|January 14, 2022
Accounting for missing data caused by drug cessation in observational comparative effectiveness research: a simulation studyDenis Mongin, Kim Lauper, Axel Finckh, et al.
Arthritis and Rheumatism|September 8, 2011
Symptomatic effects of chondroitin 4 and chondroitin 6 sulfate on hand osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial at a single centerCem Gabay, Carole Medinger-Sadowski, Danielle Gascon, et al.
Swiss Medical Weekly|January 27, 2009
Clinical experience with mycophenolate mofetil in systemic autoimmune conditions refractory to common immunosuppressive therapiesCédric Bandelier, Pierre André Guerne, Stéphane Genevay, et al.
Pageof 23

Showing results (51-60 of 225) with videos related to

Sort By:
Pageof 23
Arthritis and Rheumatism|February 1, 2007
Methotrexate as an alternative therapy for chronic calcium pyrophosphate deposition disease: an exploratory analysisAmélie Chollet-Janin, Axel Finckh, Jean Dudler, et al.
Joint Bone Spine|July 10, 2013
Primary prevention of rheumatoid arthritis: a qualitative study in a high-risk populationFiona Novotny, Sylvie Haeny, Patricia Hudelson, et al.
Obesity (Silver Spring, Md.)|February 7, 2009
BMI and severity of clinical and radiographic signs of hip osteoarthritisAnne Lübbeke, Sylvain Duc, Guido Garavaglia, et al.
Annals of the Rheumatic Diseases|February 2, 2012
Differential drug retention between anti-TNF agents and alternative biological agents after inadequate response to an anti-TNF agent in rheumatoid arthritis patientsSophie Martin Du Pan, Almut Scherer, Cem Gabay, et al.
Frontiers in Medicine|July 24, 2023
Brief report: can COVID-19 infection trigger rheumatoid arthritis-associated autoimmunity in individuals at risk for the disease? A nested cohort studyCeline Lamacchia, Benoit Gilbert, Olivia Studer, et al.
The Journal of Infectious Diseases|August 4, 2023
Susceptibility to COVID-19 and Immunologic Response to Vaccination in Patients With Immune-Mediated Inflammatory DiseasesAxel Finckh, Adrian Ciurea, Catherine E Raptis, et al.
BMJ Open|February 8, 2024
Comparative effectiveness of biologics in patients with rheumatoid arthritis stratified by body mass index: a cohort study in a Swiss registryEnriqueta Vallejo-Yagüe, Theresa Burkard, Axel Finckh, et al.
Annals of the Rheumatic Diseases|January 14, 2022
Accounting for missing data caused by drug cessation in observational comparative effectiveness research: a simulation studyDenis Mongin, Kim Lauper, Axel Finckh, et al.
Arthritis and Rheumatism|September 8, 2011
Symptomatic effects of chondroitin 4 and chondroitin 6 sulfate on hand osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial at a single centerCem Gabay, Carole Medinger-Sadowski, Danielle Gascon, et al.
Swiss Medical Weekly|January 27, 2009
Clinical experience with mycophenolate mofetil in systemic autoimmune conditions refractory to common immunosuppressive therapiesCédric Bandelier, Pierre André Guerne, Stéphane Genevay, et al.
Pageof 23